Health resource utilization and cost before versus after initiation of second-generation long-acting injectable antipsychotics among adults with schizophrenia in Alberta, Canada: a retrospective, observational single-arm study

BACKGROUND: Long-acting injectable (LAI) antipsychotics, along with community treatment orders (CTOs), are used to improve treatment effectiveness through adherence among individuals with schizophrenia. Understanding real-world medication adherence, and healthcare resource utilization (HRU) and cost...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Kai On, Klarenbach, Scott W., Martins, Karen J. B., Chue, Pierre, Dursun, Serdar M., Snaterse, Mark, Guigue, Alexis, So, Helen, Luu, Huong, Vu, Khanh, Richer, Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250716/
https://www.ncbi.nlm.nih.gov/pubmed/35780116
http://dx.doi.org/10.1186/s12888-022-04075-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250716/
https://www.ncbi.nlm.nih.gov/pubmed/35780116
http://dx.doi.org/10.1186/s12888-022-04075-y

Ejemplares similares